- J&J and the US Department of Health and Human Services have expanded an agreement to support the next phase of COVID-19 vaccine candidate research and development
- Janssen will commit ~$604M while BARDA will commit ~$454M to support the ongoing P-lll ENSEMBLE study assessing Janssen’s JNJ-78436735 as a single-dose in ~60,000 patients globally
- J&J affirmed its commitment to develop and test its vaccine candidate in accordance with high ethical standards and sound scientific principles, as outlined in a pledge made by 9 vaccine manufacturers in early 2020
Click here to read full press release/ article | Ref: PR Newswire | Image: Courier Journal
The post J&J and US Government Amends their Agreement for the Next Phase of COVID-19 Vaccine Development first appeared on PharmaShots.